NewAmsterdam Pharma Company N.V. (NAMS)

SEC filing

NewAmsterdam Pharma Company N.V.

NAMS · CIK 1936258

4 · Jan 27, 2026 · Kooij Louise Frederika sold 72.57K shares at $33.29/share ($2.4M); exercised options for 72.57K shares

Kooij Louise Frederika sold 72.57K shares at $33.29/share ($2.4M); exercised options for 72.57K shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).